187 related articles for article (PubMed ID: 7701792)
1. [Cathepsin D activity in gastric cancer].
Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer.
Manuel Del Casar J; Vizoso FJ; Abdel-Laa O; Sanz L; Martín A; Daniela Corte M; Bongera M; García Muñiz JL; Fueyo A
J Surg Oncol; 2004 Apr; 86(1):16-21. PubMed ID: 15048675
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma.
Russo A; Bazan V; Migliavacca M; Zanna I; Tubiolo C; Tumminello FM; Dardanoni G; Cajozzo M; Bazan P; Modica G; Latteri M; Tomasino RM; Colucci G; Gebbia N; Leto G
Clin Cancer Res; 2000 Jan; 6(1):178-84. PubMed ID: 10656448
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis.
Hoshi T; Sasano H; Kato K; Yabuki N; Ohara S; Konno R; Asaki S; Toyota T; Tateno H; Nagura H
Anticancer Res; 1998; 18(6A):4347-53. PubMed ID: 9891491
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and immunocytochemical localization of cathepsin E compared with cathepsin D.
Sakai H; Saku T; Kato Y; Yamamoto K
Adv Exp Med Biol; 1991; 306():361-4. PubMed ID: 1812728
[No Abstract] [Full Text] [Related]
8. Multiple early gastric cancer with gastritis cystica profunda showing various histological types.
Tsuji T; Iwahashi M; Nakamori M; Ueda K; Ishida K; Naka T; Ojima T; Akamatsu H; Yamaue H
Hepatogastroenterology; 2008; 55(84):1150-2. PubMed ID: 18705349
[TBL] [Abstract][Full Text] [Related]
9. Activity and tissue localization of cathepsin D in non small cell lung cancer.
Chyczewski L; Płoński A; Chyczewska E; Furman M; Ostrowska H; Nikliński J; Kozłowski M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of manganese superoxide dismutase, copper/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa.
Hwang TS; Choi HK; Han HS
Eur J Surg Oncol; 2007 May; 33(4):474-9. PubMed ID: 17129702
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer.
Krueger S; Kalinski T; Hundertmark T; Wex T; Küster D; Peitz U; Ebert M; Nägler DK; Kellner U; Malfertheiner P; Naumann M; Röcken C; Roessner A
J Pathol; 2005 Sep; 207(1):32-42. PubMed ID: 16025436
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Jin DK; Kim S
J Surg Res; 2007 Dec; 143(2):344-9. PubMed ID: 17688884
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
15. [Epithelial dysplasia of the gastric mucosa in infiltrative cancer].
Butov IuL; Mril' VN
Vrach Delo; 1988 Oct; (10):46-9. PubMed ID: 2851218
[No Abstract] [Full Text] [Related]
16. [Characteristic of inflammatory infiltrate of gastric mucosa in patients with grade II-III gastric dysplasia and of stomach cancer].
Evtushenko VA; Vusik MV; Karakeshisheva MB; Pleshko RI; Ermolaeva LA
Klin Med (Mosk); 2008; 86(11):48-53. PubMed ID: 19177795
[TBL] [Abstract][Full Text] [Related]
17. [The clinico-morphological characteristics, diagnosis and treatment of early stomach cancer].
Simonov NN; Anan'ev NV
Vestn Khir Im I I Grek; 1997; 156(1):28-31. PubMed ID: 9163189
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
20. [Activity of cathepsin D in some neoplasms of the gastrointestinal tract].
Kiluk M; Skrzydlewski Z; Kiluk A; Woroniecki A; Rucińska M; Kozłowski L
Pol Merkur Lekarski; 1997 May; 2(11):307-8. PubMed ID: 9377676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]